Medico Intercontinental Limite
BSE: MIL
Prev Close
32.35
Open Price
33.96
Volume
298
Today Low / High
32 / 33.96
52 WK Low / High
26 / 45
Range
31 - 35
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 33.04, reflecting a change of 0.69 (2.13292%). The expected target range on the BSE is 31 - 35. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Medico Intercontinental Limite Graph
Medico Intercontinental Limite Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Medico Intercontinental Limite T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 33.04, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 33.04 | 33.37 | 30.03 - 36.71 |
| 33.70 | 26.96 - 40.44 | ||
| 34.03 | 23.82 - 44.24 | ||
| Bearish Scenario | 33.04 | 32.71 | 29.44 - 35.98 |
| 32.38 | 25.90 - 38.86 | ||
| 32.05 | 22.43 - 41.66 |
Overview of Medico Intercontinental Limite
ISIN
INE858Q01019
Industry
Financial - Conglomerates
Vol.Avg
11,309
Market Cap
331,200,000
Last Dividend
0
Official Website
IPO Date
2024-12-30
DCF Diff
-65.31
DCF
105
Financial Ratios Every Investor Needs
Stock Dividend of MIL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-06-23 | June 23, 23 | 0.1 | 0.1 | 2023-06-23 | 2023-07-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 96.02 Cr | 74.60 Cr | 21.41 Cr | 0.2230 | 0.00 Cr | 5.15 Cr | 7.61 Cr | 5.06 Cr | 5.04 | 8.78 Cr | 0.0527 |
| 2024-03-31 | 71.51 Cr | 54.88 Cr | 16.63 Cr | 0.2326 | 0.00 Cr | 0.70 Cr | 10.21 Cr | 3.95 Cr | 3.95 | 6.22 Cr | 0.0552 |
| 2023-03-31 | 76.23 Cr | 62.30 Cr | 13.92 Cr | 0.1827 | 0.00 Cr | 0.79 Cr | 5.13 Cr | 3.61 Cr | 5.61 | 5.76 Cr | 0.0473 |
| 2022-03-31 | 74.38 Cr | 60.85 Cr | 13.53 Cr | 0.1819 | 0.00 Cr | 0.50 Cr | 9.08 Cr | 3.10 Cr | 9.54 | 5.33 Cr | 0.0417 |
| 2021-03-31 | 69.77 Cr | 57.63 Cr | 12.14 Cr | 0.1741 | 0.00 Cr | 0.53 Cr | 4.83 Cr | 2.58 Cr | 7.93 | 4.96 Cr | 0.0369 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.69 Cr | 75.76 Cr | 27.12 Cr | 48.6495 Cr | 16.92 Cr | 14.23 Cr | 9.24 Cr | 14.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 12.7636 Cr |
| 2024-03-31 | 3.37 Cr | 56.04 Cr | 11.01 Cr | 45.0321 Cr | 4.85 Cr | 1.49 Cr | 10.47 Cr | 2.39 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 8.9907 Cr |
| 2023-03-31 | 6.79 Cr | 58.88 Cr | 17.69 Cr | 41.1850 Cr | 4.72 Cr | -2.07 Cr | 8.88 Cr | 1.44 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 15.3641 Cr |
| 2022-03-31 | 1.87 Cr | 31.92 Cr | 19.29 Cr | 12.6351 Cr | 8.74 Cr | 6.87 Cr | 7.88 Cr | 1.22 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 13.0307 Cr |
| 2021-03-31 | 0.51 Cr | 30.65 Cr | 21.11 Cr | 9.5354 Cr | 9.31 Cr | 8.79 Cr | 9.11 Cr | 1.21 Cr | 0.00 Cr | 0.00 Cr | 0.16 Cr | 14.5435 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -7.1145 Cr | -2.1868 Cr | 8.6260 Cr | -9.1139 Cr | -0.6753 Cr | 2.6899 Cr | -1.9994 Cr | 6.9732 Cr | 12.0695 Cr | 0.0000 Cr | 1.1955 Cr |
| 2024-03-31 | 5.5766 Cr | -8.5388 Cr | -0.4579 Cr | 4.3418 Cr | -3.4202 Cr | 3.3652 Cr | -1.2348 Cr | 3.9471 Cr | -0.3465 Cr | -0.1000 Cr | -1.5623 Cr |
| 2023-03-31 | -10.1032 Cr | -5.3847 Cr | 20.4082 Cr | -10.5250 Cr | 4.9203 Cr | 6.7854 Cr | -0.4218 Cr | 3.6082 Cr | -3.9150 Cr | 0.0000 Cr | -0.9956 Cr |
| 2022-03-31 | 3.8494 Cr | -1.2980 Cr | -1.2010 Cr | 3.6381 Cr | 1.3503 Cr | 1.8651 Cr | -0.2113 Cr | 3.0997 Cr | -0.2988 Cr | 0.0000 Cr | 1.2293 Cr |
| 2021-03-31 | 5.8182 Cr | -0.9403 Cr | -5.1419 Cr | 5.6093 Cr | -0.2640 Cr | 0.5148 Cr | -0.2089 Cr | 2.5762 Cr | -6.5328 Cr | 0.0000 Cr | -0.4338 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 19.85 Cr | 14.35 Cr | 5.49 Cr | 0.2768 | 0.16 Cr | -1.65 Cr | -0.22 | 1.93 Cr | -0.0833 |
| 2025-09-30 | 20.40 Cr | 16.76 Cr | 3.64 Cr | 0.1784 | -2.84 Cr | -1.65 Cr | -1.65 | -0.33 Cr | -0.0810 |
| 2025-06-30 | 21.35 Cr | 16.08 Cr | 5.27 Cr | 0.2469 | 3.32 Cr | -0.68 Cr | -0.68 | 0.93 Cr | -0.0318 |
| 2025-03-31 | 21.39 Cr | 16.91 Cr | 4.48 Cr | 0.2095 | 1.72 Cr | 1.17 Cr | 1.17 | 2.08 Cr | 0.0546 |
| 2024-12-31 | 19.15 Cr | 14.58 Cr | 4.57 Cr | 0.2387 | 1.78 Cr | 1.17 Cr | 1.17 | 2.12 Cr | 0.0613 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 4.40 Cr | 0.00 Cr | 4.40 Cr | 30.45 Cr | 12.88 Cr | 54.94 Cr | 35.55 Cr | 116.55 Cr | 80.30 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -48.65 Cr |
| 2025-03-31 | 2.69 Cr | 0.00 Cr | 2.69 Cr | 33.86 Cr | 9.24 Cr | 56.58 Cr | 3.62 Cr | 75.76 Cr | 27.12 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -47.76 Cr |
| 2024-09-30 | 6.24 Cr | 0.00 Cr | 6.24 Cr | 32.24 Cr | 7.35 Cr | 47.98 Cr | 4.05 Cr | 67.19 Cr | 19.44 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -0.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 1.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.63 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Financial - Conglomerates
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Bajaj Finserv Ltd. | BAJAJFINSV | ₹1,867.80 | ₹2,983,805,186,109.00 | ₹884,672.00 |
| Aditya Birla Capital Limited | ABCAPITAL | ₹332.50 | ₹870,847,425,000.00 | ₹2,600,010.00 |
| Indigrid Infrastruct Trst | INDIGRID-IV | ₹165.20 | ₹157,363,738,000.00 | ₹509,627.00 |
| Indigrid Infrastructure Trust | INDIGRID | ₹142.23 | ₹118,726,800,570.00 | ₹288,090.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Medico Intercontinental Limite
The CEO is Dilipkumar Bhogilal Shah.
The current price is ₹33.12.
The range is ₹26-49.9.
The market capitalization is ₹33.12 crores.
The P/E ratio is -11.77.
The company operates in the Financial Services sector.
Overview of Medico Intercontinental Limite (ISIN: INE858Q01019) is a leading Financial - Conglomerates in India. With a market capitalization of ₹33.12 crores and an average daily volume of 11,309 shares, it operates in the Financial - Conglomerates. The company last declared a dividend of ₹0.